Today marks the beginning of TIDES: Oligonucleotides and Peptide Therapeutics Europe 2024 in Hamburg! Monika Wisniewska-Usielska and Filip Zdrodowski are representing SyVento BioTech at this premier event focused on oligonucleotides, peptides, mRNA technologies, and the future of drug delivery.
We’re thrilled to be part of discussions on the latest breakthroughs in nucleic acid-based therapies and to hear from world-renowned experts about the future of precision medicine and therapeutic innovation.